Stock Analysis

Riskmonster.com Third Quarter 2025 Earnings: EPS: JP¥14.47 (vs JP¥5.29 in 3Q 2024)

TSE:3768
Source: Shutterstock

Riskmonster.com (TSE:3768) Third Quarter 2025 Results

Key Financial Results

  • Revenue: JP¥960.0m (up 2.3% from 3Q 2024).
  • Net income: JP¥108.0m (up 170% from 3Q 2024).
  • Profit margin: 11% (up from 4.3% in 3Q 2024).
  • EPS: JP¥14.47 (up from JP¥5.29 in 3Q 2024).
earnings-and-revenue-history
TSE:3768 Earnings and Revenue History February 12th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Riskmonster.com shares are up 3.9% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Riskmonster.com has 3 warning signs (and 2 which are a bit concerning) we think you should know about.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:3768

Riskmonster.com

Provides credit management and ASP cloud services in Japan.

Adequate balance sheet average dividend payer.

Community Narratives

AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Fair Value SEK 2.55k|37.11% undervalued
Unike
Unike
Community Contributor
Leading the Charge in SME SaaS Innovation
Fair Value SEK 100.02|23.535% undervalued
Investingwilly
Investingwilly
Community Contributor
Brookfield Corporation is a solid BUY for a long-term portfolio
Fair Value CA$82.23|1.7389999999999999% overvalued
Jonataninho
Jonataninho
Community Contributor